Ascendis Pharma
ASND
ASND
26 hedge funds and large institutions have $223M invested in Ascendis Pharma in 2016 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 7 increasing their positions, 6 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
4% more funds holding
Funds holding: 25 → 26 (+1)
Holders
26
Holding in Top 10
4
Calls
–
Puts
–
Top Buyers
| 1 | +$9.09M | |
| 2 | +$1.94M | |
| 3 | +$693K | |
| 4 |
Morgan Stanley
New York
|
+$425K |
| 5 |
GCP
GSA Capital Partners
London,
United Kingdom
|
+$347K |
Top Sellers
| 1 | -$1.81M | |
| 2 | -$592K | |
| 3 | -$265K | |
| 4 |
AA
ALPS Advisors
Denver,
Colorado
|
-$89.8K |
| 5 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$53.7K |